Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Possibility of vaccine to prevent skin cancer

Written by | 17 Jan 2022

Research by the Oregon State University College of Pharmacy suggests that a vaccine stimulating production of a protein critical to the skin’s antioxidant network could help people bolster… read more.

How the brain’s blue spot helps us focus our attention

Written by | 16 Jan 2022

The neurotransmitter noradrenaline regulates our brain’s sensitivity to relevant information. How can we shift from a state of inattentiveness to one of highest attention? The locus coeruleus, literally… read more.

Sorting cancers by ‘immune archetypes’ represents potential new approach to developing precision immunotherapies

Written by | 16 Jan 2022

Common immune microenvironments across different types of cancer. Using data from over 300 patient tumors, researchers have described 12 classes of ‘immune archetypes’ to classify cancer tumors. Their… read more.

Remembering faces and names can be improved during sleep

Written by | 16 Jan 2022

For those who rarely forget a face, but struggle with names, the remedy for boosting learning may as near as your pillow. New research by Northwestern University is… read more.

Successful transplant of porcine heart into adult human with end-stage heart disease

Written by | 15 Jan 2022

In a first-of-its-kind surgery, a 57-year-old patient with terminal heart disease received a successful transplant of a genetically-modified pig heart and is still doing well three days later…. read more.

Adult epilepsy treatment reduces seizures in children

Written by | 15 Jan 2022

Seizures were reduced in children as young as 3 who received responsive neurostimulation. A surgical treatment commonly used to reduce epileptic seizures in adults also is effective and… read more.

New real-world data show high rate of patient adherence to Tepezza for thyroid eye disease (TED) – Horizon Therapeutics

Written by | 14 Jan 2022

Horizon Therapeutics plc announced findings of a real-world adherence analysis of Tepezza for the treatment of TED ( Thyroid Eye Disease) at the American Academy of Ophthalmology Annual… read more.

EMA gets a budget boost

Written by | 14 Jan 2022

The EU drug regulator, the European Medicines Agency (EMA), has a beefed-up budget for 2022 and plans to grow further in the years ahead. The watchdog’s Management Board… read more.

Can a dangerous microbe offer a new way to silence pain?

Written by | 13 Jan 2022

Deadly anthrax toxin blocks multiple types of pain in mice, study shows. Anthrax has a scary reputation. Widely known to cause serious lung infections in humans and unsightly,… read more.

EU backs new COVID-19 treatments

Written by | 13 Jan 2022

The European Medicines Agency (EMA) has authorised several new therapies and vaccines for COVID-19 which offer fresh hope of containing the two-year old pandemic, the EU drug watchdog… read more.

Spicy breast milk?

Written by | 12 Jan 2022

Breast milk is the first food that babies consume. Various studies have suggested that the “taste experience” in early childhood influences eating behavior in adults. Unlike standardized infant… read more.

EMA approved 91 products in 2021

Written by | 12 Jan 2022

Thirteen new medicines were given the green light at the December meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP). This brings to… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.